“Texas vs. Tylenol” SHOWDOWN: AG Paxton Sues J&J, Kenvue Over Alleged Autism, ADHD Risk Cover-Up
the staff of the Ridgewood blog
AUSTIN, TX – The legal battles surrounding one of the world’s most common pain relievers are escalating. Texas Attorney General Ken Paxton has filed a major lawsuit against healthcare giants Johnson & Johnson (J&J) and its consumer health spin-off, Kenvue, accusing the companies of knowingly marketing Tylenol (acetaminophen) as safe for pregnant women while failing to disclose potential links to neurodevelopmental disorders.
The lawsuit claims the companies violated stringent Texas consumer protection laws by misleading the public and failing to adequately warn of possible associations between prenatal acetaminophen use and conditions like Autism Spectrum Disorder (ASD) and ADHD.
The Core Allegation: Concealing Health Risks
The Texas suit centers on the argument that J&J and Kenvue prioritized profits over public health by not updating their warning labels. It references a review conducted by researchers at Harvard and Mount Sinai that found correlations between prenatal acetaminophen exposure and neurodevelopmental outcomes, though it stopped short of establishing a definitive causal link.
The lawsuit gains political visibility by citing recent public statements from high-profile figures, including President Donald Trump and Health Secretary Robert F. Kennedy Jr., who have raised concerns about the issue.
Medical Community Pushback and Corporate Defense
The claims in the lawsuit are highly contentious and have drawn sharp criticism from the medical community:
- Health Experts Disagree: Leading medical groups and health experts have disputed the conclusions linking acetaminophen to these disorders, stating that the current evidence base does not support a causal relationship and that Tylenol remains an essential and safe option for pain relief during pregnancy when used as directed.
The corporate defendants are also preparing for a legal fight:
- Kenvue’s Stance: Kenvue, which inherited the consumer health business in 2023, maintains that Tylenol is safe for use during pregnancy, adhering to guidance from major health authorities.
- J&J’s Defense: Johnson & Johnson has stated that following the 2023 divestiture of its consumer division, it retains no liability for Tylenol. However, the Texas lawsuit directly challenges this, alleging the corporate restructuring was an unlawful attempt to shield assets from future legal liability.
The case, dubbed “Texas vs. Tylenol,” is set to be a landmark legal battle that could significantly impact how over-the-counter medications are labeled and marketed to pregnant women across the country.
Tell your story #TheRidgewoodblog , #Indpendentnews, #information, #advertise, #guestpost, #affiliatemarketing,#NorthJersey, #NJ , #News, #localnews, #bergencounty, #sponsoredpost, #SponsoredContent, #contentplacement , #linkplacement, Email: [email protected]
The trial attorney class-action lawsuit(s) begin. Next up? TV commercials asking, “Did you consume Tylenol while pregnant? Does little Tommy have ADHD”? Call 1-800-TYLENOL. Lawyers are on hand to take your calls.